FDA Using Authority Under Food Safety Modernization Act To Control Dietary Supplements

On Wednesday, November 20, 2013, the Food and Drug Administration (FDA) issued a notice advising consumers that the product Slim Max should not be purchased or used. Slim Max, a weight loss product, was found to contain Sibutramine and Phenolphthalein, according to FDA laboratory analysis. Due to safety concerns, Sibutramine was removed from the market in October 2010. Sibutramine can substantially increase blood pressure and/or pulse rate in some users which may present a significant risk for patients with some medical conditions. Phenolphthalein is classified by the FDA as “not generally recognized as safe and effective.”

To read the rest of this article, please visit Risky Business – Avoiding Product Liability, Commercial, and Other Litigation.

Leave a Reply

Next ArticleThis Week's Life Science Headlines